QuartzBio part of Precision for Medicine

PrecisionMed helps facilitate breakthroughs in genetics, drug discovery, biomarker research, and molecular diagnostics. We are the world's largest private source of Human Cerebral Spinal Fluid. PrecisionMed is constantly collecting samples with our predictive biobanking approach. PrecisionMed has been providing researchers with the highest quality human biological material for research since 1996. PrecisionMed has been cited in numerous scientific journals as a sample source. PrecisionMed has the largest commercially-available CSF biorepository on the planet. Our extensive inventory is available immediately and includes the PrecisionMed guarantee. With our vast partner network we can provide nearly any human biological sample, and you can rely on us to deliver.

We are engaged in COVID-19 research with comprehensive solutions for all areas of therapeutic, vaccine and diagnostic development. And while able to execute individual assays as needed, we specialize in holistic solutions that take into account the entirety of a clinical development project, especially for projects where we are working in conjunction with our clinical trials, regulatory, and data science teams for the integrated delivery of solutions for all aspects of a clinical development program. Additionally, we offer prospective collections for any study need. Precision for Medicine is part of the Precision Medicine Group, an integrated team of experts that extends Precision for Medicine’s therapeutic development capabilities beyond approval and into launch strategies, marketing communication, and payer insights. As one company, the Precision Medicine Group helps pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment. With experience built on 150+ orphan disease projects covering 80+ rare diseases, we know how to anticipate logistical and regulatory obstacles and craft bold solutions that drive rare disease development programs. As one of the top-rated clinical research companies, we support development programs with state-of-the-art immune monitoring solutions and immunogenicity testing expertise. Our integrated clinical development, biomarker assay, regulatory strategy and commercialization capabilities deliver unique value for CDx programs.

We are engaged in COVID-19 research with comprehensive solutions for all areas of therapeutic, vaccine and diagnostic development. And while able to execute individual assays as needed, we specialize in holistic solutions that take into account the entirety of a clinical development project, especially for projects where we are working in conjunction with our clinical trials, regulatory, and data science teams for the integrated delivery of solutions for all aspects of a clinical development program. Additionally, we offer prospective collections for any study need. Precision for Medicine is part of the Precision Medicine Group, an integrated team of experts that extends Precision for Medicine’s therapeutic development capabilities beyond approval and into launch strategies, marketing communication, and payer insights. As one company, the Precision Medicine Group helps pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment. With experience built on 150+ orphan disease projects covering 80+ rare diseases, we know how to anticipate logistical and regulatory obstacles and craft bold solutions that drive rare disease development programs. As one of the top-rated clinical research companies, we support development programs with state-of-the-art immune monitoring solutions and immunogenicity testing expertise. Our integrated clinical development, biomarker assay, regulatory strategy and commercialization capabilities deliver unique value for CDx programs.

Precion specializes in the development, validation, and profiling of LC-MS/MS based small molecule biomarker assays. Precion’s method, a metabolite based test, reveals what is actually happening. Partner with Precion and let our team develop your next superior assay. We are pioneers in the biomarker field and strive for excellence with accuracy and development of assays. Precion specializes in the development, validation, and profiling of LC-MS/MS based small molecule biomarker assays and our in-house synthesis capabilities for stable isotope labeled internal standards allow for accurate, dependable, and reproducible results. Our focus on targeting metabolites allow us to diagnose chronic disease effectively. Innovative testing, a strong R&D pipeline, and an extensive patent portfolio makes our products unique. Allowing us the ability to deep profile key disease pathways, provide robust biomarker selection, and access to critical clinical resources.

We are a technology company operating at the intersection of AI, Physics and Biology to automate the physical exam from data collection to triage and routing to make preventive personalized healthcare available to everyone. Q Bio’s HQ is in sunny San Carlos, CA. We are a multidisciplinary team from a variety of backgrounds, all with the determination to succeed together. We are accountable to each other, committed to collaboration, and seek to inspire one another. At Q Bio, we believe assumptions are made to be broken. Q Bio is developing three technology pillars that will ultimately be vertically integrated and combined with commodity vitals & biochemistry collection to enable Digital Twins and Large Biological Model-powered personalized health forecasts at population scale. Quantitative, generates reproducible data optimized for machine interpretation. We are piloting the Gemini Exam under a research protocol at our site in Redwood City, with more availability to come via Gemini Platform partners.

We are a hybrid CRO leveraging our vertically integrated model to build a life sciences biorepository with industry leading clinical and molecular data sets. BocaBio has been building one of the largest, multi-national, data-rich, commercial biobanks. We are passionate about transforming patients’ lives and understand that we can accomplish this by driving the science of our clients forward. BocaBio has a passionate commitment to in vitro diagnostics. Boca Bio’s vertically integrated platform with a data-centric modality provides true end to end solutions for accelerating the realization of cutting edge technological advancements. We believe that good business means a better world. With an ever-growing, multi-national biobank, BocaBio can provide researchers with a broad range of highly characterized human biospecimens across many indications. With a sharp focus on Oncology, we also collect and store specimens from cardiovascular disease, gastrointestinal diseases, neuro-degenerative disease and others.